CELLEBRITE DI LTD (CLBT) Stock Fundamental Analysis
NASDAQ:CLBT - Nasdaq - IL0011794802 - Common Stock - Currency: USD
Taking everything into account, CLBT scores 5 out of 10 in our fundamental rating. CLBT was compared to 284 industry peers in the Software industry. CLBT is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. While showing a medium growth rate, CLBT is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year CLBT was profitable.
In the past year CLBT had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CLBT reported negative net income in multiple years.
CLBT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of -40.98%, CLBT is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
The Return On Equity of CLBT (-84.22%) is worse than 75.36% of its industry peers.
The Return On Invested Capital of CLBT (11.38%) is better than 88.41% of its industry peers.
CLBT had an Average Return On Invested Capital over the past 3 years of 7.06%. This is below the industry average of 11.91%.
The 3 year average ROIC (7.06%) for CLBT is below the current ROIC(11.38%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -40.98% | ||
| ROE | -84.22% | ||
| ROIC | 11.38% |
ROA(3y)-9.14%
ROA(5y)-1.85%
ROE(3y)-54.72%
ROE(5y)N/A
ROIC(3y)7.06%
ROIC(5y)7.59%
1.3 Margins
CLBT's Operating Margin of 14.18% is amongst the best of the industry. CLBT outperforms 83.33% of its industry peers.
In the last couple of years the Operating Margin of CLBT has grown nicely.
Looking at the Gross Margin, with a value of 84.40%, CLBT belongs to the top of the industry, outperforming 90.94% of the companies in the same industry.
In the last couple of years the Gross Margin of CLBT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.18% | ||
| PM (TTM) | N/A | ||
| GM | 84.4% |
OM growth 3Y10.9%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.66%
GM growth 5Y1.3%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CLBT is still creating some value.
CLBT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CLBT has more shares outstanding
CLBT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
CLBT has an Altman-Z score of 8.03. This indicates that CLBT is financially healthy and has little risk of bankruptcy at the moment.
CLBT has a Altman-Z score of 8.03. This is in the better half of the industry: CLBT outperforms 76.09% of its industry peers.
CLBT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 8.03 |
ROIC/WACC1.25
WACC9.11%
2.3 Liquidity
A Current Ratio of 1.92 indicates that CLBT should not have too much problems paying its short term obligations.
CLBT's Current ratio of 1.92 is in line compared to the rest of the industry. CLBT outperforms 58.33% of its industry peers.
A Quick Ratio of 1.89 indicates that CLBT should not have too much problems paying its short term obligations.
CLBT has a Quick ratio (1.89) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.92 | ||
| Quick Ratio | 1.89 |
3. Growth
3.1 Past
CLBT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 38.16%, which is quite impressive.
Looking at the last year, CLBT shows a very strong growth in Revenue. The Revenue has grown by 23.41%.
Measured over the past years, CLBT shows a quite strong growth in Revenue. The Revenue has been growing by 18.47% on average per year.
EPS 1Y (TTM)38.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-9.09%
Revenue 1Y (TTM)23.41%
Revenue growth 3Y17.68%
Revenue growth 5Y18.47%
Sales Q2Q%17.24%
3.2 Future
CLBT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.77% yearly.
The Revenue is expected to grow by 14.46% on average over the next years. This is quite good.
EPS Next Y2.49%
EPS Next 2Y10.32%
EPS Next 3Y15.53%
EPS Next 5Y10.77%
Revenue Next Year21.23%
Revenue Next 2Y19.41%
Revenue Next 3Y18.75%
Revenue Next 5Y14.46%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 45.52, the valuation of CLBT can be described as expensive.
Based on the Price/Earnings ratio, CLBT is valued a bit cheaper than the industry average as 61.59% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 29.63, CLBT is valued quite expensively.
Based on the Price/Forward Earnings ratio of 44.42, the valuation of CLBT can be described as expensive.
CLBT's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.68, CLBT is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 45.52 | ||
| Fwd PE | 44.42 |
4.2 Price Multiples
67.75% of the companies in the same industry are more expensive than CLBT, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CLBT is valued a bit cheaper than the industry average as 72.83% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.32 | ||
| EV/EBITDA | 51.22 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
CLBT's earnings are expected to grow with 15.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)18.31
PEG (5Y)N/A
EPS Next 2Y10.32%
EPS Next 3Y15.53%
5. Dividend
5.1 Amount
CLBT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
19.12
+0.05 (+0.26%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners42.12%
Inst Owner Change-2.89%
Ins Owners2.98%
Ins Owner ChangeN/A
Market Cap4.17B
Analysts84.29
Price Target28.39 (48.48%)
Short Float %0.98%
Short Ratio0.6
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)29.22%
Min EPS beat(2)0.93%
Max EPS beat(2)57.51%
EPS beat(4)4
Avg EPS beat(4)46.31%
Min EPS beat(4)0.93%
Max EPS beat(4)86.74%
EPS beat(8)8
Avg EPS beat(8)71.28%
EPS beat(12)9
Avg EPS beat(12)37.79%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.26%
Min Revenue beat(2)-0.26%
Max Revenue beat(2)2.78%
Revenue beat(4)3
Avg Revenue beat(4)1.23%
Min Revenue beat(4)-0.26%
Max Revenue beat(4)2.78%
Revenue beat(8)7
Avg Revenue beat(8)2.03%
Revenue beat(12)7
Avg Revenue beat(12)-0.16%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.59%
PT rev (3m)26.71%
EPS NQ rev (1m)-1.63%
EPS NQ rev (3m)-1.63%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 45.52 | ||
| Fwd PE | 44.42 | ||
| P/S | 10.4 | ||
| P/FCF | 34.32 | ||
| P/OCF | 31.56 | ||
| P/B | 12.42 | ||
| P/tB | 14.09 | ||
| EV/EBITDA | 51.22 |
EPS(TTM)0.42
EY2.2%
EPS(NY)0.43
Fwd EY2.25%
FCF(TTM)0.56
FCFY2.91%
OCF(TTM)0.61
OCFY3.17%
SpS1.84
BVpS1.54
TBVpS1.36
PEG (NY)18.31
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -40.98% | ||
| ROE | -84.22% | ||
| ROCE | 14.4% | ||
| ROIC | 11.38% | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 14.18% | ||
| PM (TTM) | N/A | ||
| GM | 84.4% | ||
| FCFM | 30.3% |
ROA(3y)-9.14%
ROA(5y)-1.85%
ROE(3y)-54.72%
ROE(5y)N/A
ROIC(3y)7.06%
ROIC(5y)7.59%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.94%
ROCE(5y)9.6%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y10.9%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.66%
GM growth 5Y1.3%
F-Score5
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 100.02% | ||
| Cap/Sales | 2.64% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 195.77% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.92 | ||
| Quick Ratio | 1.89 | ||
| Altman-Z | 8.03 |
F-Score5
WACC9.11%
ROIC/WACC1.25
Cap/Depr(3y)92.67%
Cap/Depr(5y)99.76%
Cap/Sales(3y)2.81%
Cap/Sales(5y)2.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-9.09%
EPS Next Y2.49%
EPS Next 2Y10.32%
EPS Next 3Y15.53%
EPS Next 5Y10.77%
Revenue 1Y (TTM)23.41%
Revenue growth 3Y17.68%
Revenue growth 5Y18.47%
Sales Q2Q%17.24%
Revenue Next Year21.23%
Revenue Next 2Y19.41%
Revenue Next 3Y18.75%
Revenue Next 5Y14.46%
EBIT growth 1Y71.21%
EBIT growth 3Y30.51%
EBIT growth 5YN/A
EBIT Next Year27.33%
EBIT Next 3Y16.14%
EBIT Next 5Y16.26%
FCF growth 1Y29.13%
FCF growth 3Y63.25%
FCF growth 5Y65.07%
OCF growth 1Y29.51%
OCF growth 3Y54.2%
OCF growth 5Y52.3%